Migdal Insurance & Financial Holdings Ltd. Bei Gene, Ltd. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$221.31 - $316.61 $404,997 - $579,396	-1,830 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$189.18 - $286.44 $179,153 - $271,258	947 Added 107.25%	1,830 $515,000
Q2 2020 Aug 11, 2020	BUY	$123.9 - $195.41 $23,912 - $37,714	193 Added 27.97%	883 $167,000
Q1 2020 May 12, 2020	BUY	$121.84 - $173.19 $39,719 - $56,459	326 Added 89.56%	690 $85,000
Q4 2019 Feb 13, 2020	BUY	$115.78 - $208.34 $22,345 - $40,209	193 Added 112.87%	364 $60,000
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $1,206 - $1,482	10 Added 6.21%	171 $21,000
Q2 2019 Aug 08, 2019	BUY	$113.99 - $146.86 $10,373 - $13,364	91 Added 130.0%	161 $20,000
Q1 2019 May 01, 2019	BUY	$122.82 - $151.83 $5,772 - $7,136	47 Added 204.35%	70 $9,000
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $2,461 - $4,028	23 New	23 $3,000

Others Institutions Holding BGNE

# of Institutions

253

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.31 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.41 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$1.13 Billion
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$1.09 Billion
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$810 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account